Here’s what happens when patients go
Unprotected From infection Due to lowered Neutrophil Counts
It’s well known that neutrophils are a patient’s first line of defense against infection.1
Chemotherapy suppresses the hematopoietic system. it also:
Suppresses
the production of critical neutrophils, greatly lowering their numbers1
Decreases
a patient’s immune defenses and increases infections1
Allows
bacterial proliferation and invasion1
Creates
chemotherapy-induced neutropenia (CIN)1
Take a closer look at neutropenia
And see why myelosuppression, including CIN, is the number one reason chemotherapy regimens are forced to be changed.2
THE TIME TO PREVENT CIN IS DURING THE NEUTROPENIA VULNERABILITY GAP3
Every day may make a difference for a patient on cytotoxic chemotherapy. Because of the significant risk of sepsis and potentially life-threatening events, CIN needs to be monitored regularly to optimize care and outcomes for patients.3
Expert Perspectives in CIN
Video Transcript
Dr. Lyman: It’s also important that patients be educated about the risk of neutropenia and the importance of being cautious, avoiding opportunities that might put them at risk for infection, family members or friends with infection, much of the same thing we’re going through now with COVID-19 is to avoid exposure to patients who might already have, in this case, the bigger problem being a bacterial infection that might pose a risk when the patient becomes neutropenic.
#CINSIGHTS
Who’s at the greatest risk for Cin?
References:
- Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004;100(2):228-237.
- Lyman GH. Management of chemotherapy-induced neutropenia with colony-stimulating factors. Eur Oncol. 2008;4(2):13-17.
- Gupta A, Abbasi B, Gupta S. Management of chemotherapy induced neutropenia—an unmet clinical need. Am J Biomed Sci & Res. 2019;4(5):313-318.
